Blood pressure medication not linked to cancer risk

More short articles on oncology: There are 568 genes that can activate cancer, researchers say7 things to understand about oncologists personal financesNo. 1 for cancer care: Whats missing from rankings for this specialty?

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.

The research, provided Aug. 31 at the European Society of Cardiology Congress, consisted of information from 31 randomized trials about blood pressure medication.

The trials involved 260,000 people and investigated five antihypertensive drug classes individually: angiotensin-converting enzyme inhibitors; angiotensin II receptor blockers; beta blockers; calcium channel blockers; and diuretics. Scientist analyzed cancer results amongst those taking part in the trials.


Utilizing blood pressure medication was not connected with an increased danger of establishing cancer, a brand-new analysis found.

Over an average of 4 years, there had to do with 15,000 new cancer diagnoses. The researchers discovered no proof that making use of any antihypertensive drug class increased the risk of cancer, despite age, gender, body size, smoking cigarettes status and previous high blood pressure drug use.